Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis after infectious mononucleosis.

Trine Rasmussen Nielsen1, Klaus Rostgaard, Nete Munk Nielsen

  • 1Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark. trn@ssi.dk

Archives of Neurology
|January 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of chronic lymphocytic leukaemia (CLL)-directed therapy on diffuse large B-cell lymphoma (DLBCL) type Richter transformation compared to de novo DLBCL in a nationwide cohort.

British journal of haematology·2026
Same author

Survival Following Neoplastic Disease in Individuals With Neurofibromatosis 1-A National Danish Population-Based Cohort Study.

International journal of cancer·2026
Same author

Disentangling shifting demographic and treatment effects on years of life lost to cancer in Denmark.

npj aging·2026
Same author

Plasma donation rates and infection risk: A multicentre observational study in Denmark.

Vox sanguinis·2026
Same author

CD20 negativity at the start of second-line therapy predicts a shorter overall survival in B-cell lymphomas.

Blood neoplasia·2026
Same author

Sex differences in cancer incidence and survival: a Danish nationwide population-based study assessing 35 cancer sites.

British journal of cancer·2026
Same journal

Incorrect Table Entries and Word.

Archives of neurology·2016
Same journal

IDEAL for CCSVI Research-Reply.

Archives of neurology·2013
Same journal

Atlas of Inherited Metabolic Diseases, 3rd ed.

Archives of neurology·2013
Same journal

Error in byline: in heterogeneity of coenzyme q10 deficiency: patient study and literature review.

Archives of neurology·2013
Same journal

This month in archives of neurology.

Archives of neurology·2013
Same journal

About this journal.

Archives of neurology·2013
See all related articles

Infectious mononucleosis significantly increases the risk of developing multiple sclerosis. This elevated risk persists for over 30 years, irrespective of patient sex, age, or infection severity.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Epidemiology

Background:

  • Epstein-Barr virus (EBV) infection, commonly known as infectious mononucleosis, is linked to an elevated risk of multiple sclerosis (MS).
  • Characteristics of the association between infectious mononucleosis and MS risk remain incompletely understood.

Purpose of the Study:

  • To investigate the influence of sex, age at infection, time since infection, and attained age on the risk of developing MS post-infectious mononucleosis.
  • To quantify the long-term risk of MS following infectious mononucleosis.

Main Methods:

  • A large cohort study involving 25,234 individuals tested for infectious mononucleosis in Denmark.
  • Utilized national registries for patient data, including the Danish Civil Registration System and the Danish Multiple Sclerosis Registry.

Related Experiment Videos

  • Followed the cohort from 1968 to 1996, calculating standardized incidence ratios (SIR) for MS cases.
  • Main Results:

    • A 2.27-fold increased risk of MS (SIR = 2.27) was observed in individuals with a history of infectious mononucleosis.
    • The heightened risk of MS persisted for over 30 years post-infection.
    • No significant variation in MS risk was found across different sexes, age groups, or based on the presumed severity of infectious mononucleosis.

    Conclusions:

    • Prior infectious mononucleosis is a significant risk factor for developing multiple sclerosis.
    • The increased risk of MS following infectious mononucleosis is consistent across various demographic factors and persists long-term.
    • This association underscores the importance of understanding EBV's role in MS pathogenesis.